Traws Pharma, Inc. (TRAW)
Nasdaq: TRAW · Pharmaceutical Preparations · Newtown, PA · filing with the SEC since 2003
Who owns Traws Pharma, Inc.
As filed with the SECHolders of 5% or more
6
Orbimed Advisors LLC holds 11.9% of Common Stock, as its SCHEDULE 13D/A filed May 5, 2026 says.
Directors and officers
10
report now, of 29 people on the record since 2013. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 6 named at left.
Holders of 5% or moreshare of the class, as filed
Orbimed Advisors LLC
SCHEDULE 13D/A · filed May 5, 2026 · Common Stock · 19.9% in Jan 29, 2025
Sirenia Capital Management LP
SCHEDULE 13G · filed Aug 14, 2026 · Common Stock, par value $0.01 per share
Alyeska Investment Group, L.P.
SCHEDULE 13G · filed Feb 14, 2025 · Common Stock, par value $.01 per share
Ikarian Capital, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, par value $.01 per share · 9.99% in Feb 17, 2026
Chernett Jorey
SCHEDULE 13G · filed Jan 16, 2026 · Common
Perceptive Advisors LLC
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, par value $0.01 per share · 9.99% in Nov 14, 2025
Adage Capital Management, L.P.
SCHEDULE 13G/A · filed Aug 12, 2026 · Common Stock, par value $0.01 per share · reported falling below 5%, from 9.14% in Feb 12, 2026
Ayrton Capital LLC
SCHEDULE 13G/A · filed Feb 11, 2026 · Common Stock, $0.01 par value · reported falling below 5%, from 9.9% in Feb 13, 2025
Squadron Master Fund LP
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, par value $.01 per share · reported falling below 5%, from 6.4% in May 15, 2026
What TRAW reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Trawsfynydd IPR&D
A company bought · asset acquisition · owns, named in the 10-K filed Apr 15, 2026
4 subsidiaries in 3 countries, from the list filed with the 10-K filed Mar 31, 2025.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2022 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 40 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Orbimed Capital Gp Viii LLC | 10% owner | 0 | $0 | 0 | 1 | $1.0M |